TIDMBGLF
RNS Number : 6914C
Blackstone / GSO Loan Financing Ltd
21 October 2020
RNS Announcement
Blackstone / GSO Loan Financing Limited
21 October 2020
Share Repurchase Programme
Blackstone / GSO Loan Financing Limited (the "Company")
announces that, under the general authority to buy back shares
conferred by the Company's shareholders at its Annual General
Meeting on 16 July 2020, it intends to continue buying back shares
in the market using available cash with a view to reducing the
discount to NAV at which the Company's Ordinary Shares are
currently trading.
As per the Company's prospectus issued on 23 November 2018, the
Directors may, at their absolute discretion, use available cash to
purchase in the market Ordinary Shares at any time, subject to
having been granted authority to do so, should the Ordinary Shares
trade at an average discount to NAV per Share of more than 7.5 per
cent. as measured each month over the preceding six month trading
period.
The Company has for the year-to-date repurchased 1,413,507
Ordinary Shares for an aggregate consideration of EUR857,584. The
Directors are conscious of the discount at which the Company's
Ordinary Shares are currently trading and will continue to monitor
the Company's share price rating and relevant factors such as the
Company's available cash resources, in connection with any decision
to buy back shares. The Company's approach to buybacks will also
remain under review.
Enquires:
BNP Paribas Securities Services S.C.A. 01534 813873 / 813967
N+1 Singer Advisory LLP
James Maxwell/Ben Farrow 020 7496 3000
Winterflood Investment Trusts
Neil Langford 020 3100 0000
NOTE: PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE
PERFORMANCE RESULTS AND THERE CAN BE NO ASSURANCE THAT BGLF WILL
ACHIEVE COMPARABLE RESULTS.
IMPORTANT INFORMATION
Any reference herein to future returns or distributions is a
target and not a forecast and there can be no guarantee or
assurance that it will be achieved.
This document has been issued by Blackstone / GSO Loan Financing
Limited (the "Company"), and should not be taken as an inducement
to engage in any investment activity and is for the purpose of
providing information about the Company. This document does not
constitute or form part of, and should not be construed as, any
offer for sale or subscription of, or solicitation of any offer to
buy or subscribe for, any share in the Company or securities in any
other entity, in any jurisdiction, including the United States,
Canada, Japan or South Africa nor shall it, or any part of it, or
the fact of its distribution, form the basis of, or be relied on in
connection with, any contract or investment decision whatsoever, in
any jurisdiction.
This document, and the information contained therein, is not for
viewing, release, distribution or publication in or into the United
States, Canada, Japan, South Africa or any other jurisdiction where
applicable laws prohibit its release, distribution or publication,
and will not be made available to any national, resident or citizen
of the United States, Canada, Japan or South Africa. The
distribution of this document in other jurisdictions may be
restricted by law and persons into whose possession this document
comes must inform themselves about, and observe, any such
restrictions. Any failure to comply with the restrictions may
constitute a violation of the federal securities law of the United
States and the laws of other jurisdictions.
The shares issued and to be issued by the Company (the "Shares")
have not been and will not be registered under the US Securities
Act of 1933, as amended (the "Securities Act"), or with any
securities regulatory authority of any state or other jurisdiction
of the United States. The Shares may not be offered, sold, resold,
pledged, delivered, distributed or otherwise transferred, directly
or indirectly, into or within the United States, or to, or for the
account or benefit of, US persons (as defined in Regulation S under
the Securities Act). No public offering of the Shares is being made
in the United States.
The Company has not been and will not be registered under the US
Investment Company Act of 1940, as amended (the "Investment Company
Act") and, as such, holders of the Shares will not be entitled to
the benefits of the Investment Company Act. No offer, sale, resale,
pledge, delivery, distribution or transfer of the Shares may be
made except under circumstances that will not result in the Company
being required to register as an investment company under the
Investment Company Act. Neither the U.S. Securities and Exchange
Commission (the "SEC") nor any state securities commission has
approved or disapproved of the Shares or passed upon or endorsed
the merits of the offering of the Shares or the adequacy or
accuracy of the Prospectus. Any representation to the contrary is a
criminal offence in the United States. In addition, the Shares are
subject to restrictions on transferability and resale in certain
jurisdictions and may not be transferred or resold except as
permitted under applicable securities laws and regulations.
Investors may be required to bear the financial risks of their
investment in the Shares for an indefinite period of time. Any
failure to comply with these restrictions may constitute a
violation of the securities laws of any such jurisdictions.
This document is directed only at: (i) persons having
professional experience in matters relating to investments who fall
within the definition of "investment professionals" in Article
19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005; or (ii) high net worth bodies corporate,
unincorporated associations and partnerships and trustees of high
value trusts as described in Article 49(2) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 and
persons who receive this document who do not fall within (i) or
(ii) above should not rely on or act upon this document.
No liability whatsoever (whether in negligence or otherwise)
arising directly or indirectly from the use of this document is
accepted and no representation, warranty or undertaking, express or
implied, is or will be made by the Company, or any of their
respective directors, officers, employees, advisers,
representatives or other agents ("Agents") for any information or
any of the opinions contained herein or for any errors, omissions
or misstatements. None of the Agents makes or has been authorised
to make any representation or warranties (express or implied) in
relation to the Company or as to the truth, accuracy or
completeness of this document, or any other written or oral
statement provided. In particular, no representation or warranty is
given as to the achievement or reasonableness of, and no reliance
should be placed on any projections, targets, estimates or
forecasts contained in this document and nothing in this document
is or should be relied on as a promise or representation as to the
future.
Unless otherwise indicated, the information provided herein is
based on matters as they exist as of the date of preparation and
not as of any future date. Recipients of this document are
encouraged to contact the Company's representatives to discuss the
procedures and methodologies used to make the projections and other
information provided herein.
All investments are subject to risk, including the loss of the
principal amount invested. Past performance is not necessarily
indicative of future results, and there can be no assurance that
BGLF will achieve comparable results, will meet its target returns,
achieve its investment objectives or be able to implement its
investment strategy. Certain countries have been susceptible to
epidemics, most recently COVID-19, which may be designated as
pandemics by world health authorities. The outbreak of such
epidemics, together with any resulting restrictions on travel or
quarantines imposed, has had and will continue to have a negative
impact on the economy and business activity globally (including in
the countries in which the Company invests), and thereby is
expected to adversely affect the performance of the Company's
Investments. Furthermore, the rapid development of epidemics could
preclude prediction as to their ultimate adverse impact on economic
and market conditions, and, as a result, presents material
uncertainty and risk with respect to the Company and the
performance of its Investments. All investments to be held by the
Company involve a substantial degree of risk, including the risk of
total loss. The value of shares and the income from them is not
guaranteed and can fall as well as rise due to stock market and
currency movements. When you sell your investment you may get back
less than you originally invested. You should always seek expert
legal, financial, tax and other professional advice before making
any investment decision.
Blackstone / GSO Loan Financing Limited is a self-managed Jersey
registered alternative investment fund, and is regulated by the
Jersey Financial Services Commission. The Jersey Financial Services
Commission does not take any responsibility for the financial
soundness of the Company or for the correctness of any statements
made or expressed in this document.
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
POSBUBDGDDDDGGG
(END) Dow Jones Newswires
October 21, 2020 02:00 ET (06:00 GMT)
Blackstone Loan Financing (LSE:BGLP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Blackstone Loan Financing (LSE:BGLP)
Historical Stock Chart
From Jul 2023 to Jul 2024